295 related articles for article (PubMed ID: 22313815)
1. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
Wynn RL
Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
[No Abstract] [Full Text] [Related]
2. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
[No Abstract] [Full Text] [Related]
4. Bisphosphonate-Related Osteonecrosis of the Jaw in an 80-Year-Old Woman with Diabetes Mellitus: Case Report.
Valenzuela L; Alonso-Bouzón C; Mañas LR
J Am Geriatr Soc; 2015 Oct; 63(10):2221-2. PubMed ID: 26481002
[No Abstract] [Full Text] [Related]
5. Histopathological features of osteonecrosis of the jaw associated with bisphosphonates.
Paparella ML; Brandizzi D; Santini-Araujo E; Cabrini RL
Histopathology; 2012 Feb; 60(3):514-6. PubMed ID: 22168273
[No Abstract] [Full Text] [Related]
6. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
[TBL] [Abstract][Full Text] [Related]
7. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
Soós B; Vajta L; Szalma J
Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
[TBL] [Abstract][Full Text] [Related]
8. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Gueiros LA; Lopes MA; Leão JC
J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809
[No Abstract] [Full Text] [Related]
9. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: report of 2 cases.
Lee JJ; Cheng SJ; Wang YP; Jeng JH; Chiang CP; Kok SH
Head Neck; 2013 Jan; 35(1):E6-10. PubMed ID: 21523843
[TBL] [Abstract][Full Text] [Related]
11. Annual zoledronic acid for osteoporosis.
BMJ Group
Drug Ther Bull; 2008 Dec; 46(12):93-6. PubMed ID: 19056701
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
Lee CY; Suzuki JB
Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated osteonecrosis of the jaw 2 years after teeth extractions: a case report solved with non-invasive treatment.
Gómez-Moreno G; Arribas-Fernández MC; Fernández-Guerrero M; Boquete-Castro A; Aguilar-Salvatierra A; Guardia J; Botticelli D; Calvo-Guirado JL
Eur Rev Med Pharmacol Sci; 2014; 18(9):1391-7. PubMed ID: 24867519
[TBL] [Abstract][Full Text] [Related]
14. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Grasko JM; Herrmann RP; Vasikaran SD
J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
[No Abstract] [Full Text] [Related]
15. Drug induced osteonecrosis of the jaws.
Weeda LW
J Tenn Dent Assoc; 2006; 86(2):18-9. PubMed ID: 16895006
[No Abstract] [Full Text] [Related]
16. Osteonecrosis of the jaw.
Reilly MM; Moore S
Oncology (Williston Park); 2008 Feb; 22(2 Suppl Nurse Ed):39-41. PubMed ID: 18431898
[No Abstract] [Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: two cases and review of the literature.
Katz J; Ordoveza PA
Quintessence Int; 2014 Sep; 45(8):685-90. PubMed ID: 25019116
[TBL] [Abstract][Full Text] [Related]
18. Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.
Higuchi T; Soga Y; Muro M; Kajizono M; Kitamura Y; Sendo T; Sasaki A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):547-551. PubMed ID: 29574058
[TBL] [Abstract][Full Text] [Related]
19. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Sieber P; Lardelli P; Kraenzlin CA; Kraenzlin ME; Meier C
Clin Drug Investig; 2013 Feb; 33(2):117-22. PubMed ID: 23184667
[TBL] [Abstract][Full Text] [Related]
20. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
